ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)

por Masfarré, Laura, Vidal, Joana, Fernández-Rodríguez, Concepción, Montagut, Clara
Publicado 2021

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer

por Cremolini, Chiara, Montagut, Clara, Ronga, Philippe, Venturini, Filippo, Yamaguchi, Kensei, Stintzing, Sebastian, Sobrero, Alberto
Publicado 2023

Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report

por Casadevall, David, Vidal, Joana, Gallardo, Fernando, Zuccarino, Flavio, Arumí-Uría, Montserrat, Dalmases, Alba, Bellosillo, Beatriz, Montagut, Clara
Publicado 2016

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

por Goldberg, Richard M, Montagut, Clara, Wainberg, Zev A, Ronga, Philippe, Audhuy, François, Taieb, Julien, Stintzing, Sebastian, Siena, Salvatore, Santini, Daniele
Publicado 2018

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

por Taieb, Julien, Jung, Andreas, Sartore-Bianchi, Andrea, Peeters, Marc, Seligmann, Jenny, Zaanan, Aziz, Burdon, Peter, Montagut, Clara, Laurent-Puig, Pierre
Publicado 2019

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

por García‐Alfonso, Pilar, Benavides, Manuel, Falcó, Esther, Muñoz, Andrés, Gómez, Auxiliadora, Sastre, Javier, Rivera, Fernando, Montagut, Clara, Salgado, Mercedes, López‐Ladrón, Amelia, López, Rafael, Ruiz de Mena, Inmaculada, Durán, Gema, Aranda, Enrique
Publicado 2018

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

por García-Foncillas, Jesús, Tabernero, Josep, Élez, Elena, Aranda, Enrique, Benavides, Manuel, Camps, Carlos, Jantus-Lewintre, Eloisa, López, Rafael, Muinelo-Romay, Laura, Montagut, Clara, Antón, Antonio, López, Guillermo, Díaz-Rubio, Eduardo, Rojo, Federico, Vivancos, Ana
Publicado 2018

IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in Cancer

por Colomer, Carlota, Margalef, Pol, Villanueva, Alberto, Vert, Anna, Pecharroman, Irene, Solé, Laura, González-Farré, Mónica, Alonso, Josune, Montagut, Clara, Martinez-Iniesta, Maria, Bertran, Joan, Borràs, Eva, Iglesias, Mar, Sabidó, Eduard, Bigas, Anna, Boulton, Simon J., Espinosa, Lluís
Publicado 2019

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Publicado 2012

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorecta...

por Van Cutsem, Eric, Huijberts, Sanne, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan, Elez, Elena, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Yoshino, Takayuki, Wasan, Harpreet, Desai, Jayesh, Ciardiello, Fortunato, Gollerkeri, Ashwin, Christy-Bittel, Janna, Maharry, Kati, Sandor, Victor, Schellens, Jan H.M., Kopetz, Scott, Tabernero, Josep
Publicado 2019

Identification of ALK Gene Alterations in Urothelial Carcinoma

por Bellmunt, Joaquim, Selvarajah, Shamini, Rodig, Scott, Salido, Marta, de Muga, Silvia, Costa, Irmgard, Bellosillo, Beatriz, Werner, Lillian, Mullane, Stephanie, Fay, André P., O'Brien, Robert, Barretina, Jordi, Minoche, André E., Signoretti, Sabina, Montagut, Clara, Himmelbauer, Heinz, Berman, David M., Kantoff, Philip, Choueiri, Toni K., Rosenberg, Jonathan E.
Publicado 2014

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

por Van Emburgh, Beth O., Arena, Sabrina, Siravegna, Giulia, Lazzari, Luca, Crisafulli, Giovanni, Corti, Giorgio, Mussolin, Benedetta, Baldi, Federica, Buscarino, Michela, Bartolini, Alice, Valtorta, Emanuele, Vidal, Joana, Bellosillo, Beatriz, Germano, Giovanni, Pietrantonio, Filippo, Ponzetti, Agostino, Albanell, Joan, Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Montagut, Clara, Bardelli, Alberto
Publicado 2016

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

por Vera, Ruth, Gómez, María Luisa, Ayuso, Juan Ramón, Figueras, Joan, García-Alfonso, Pilar, Martínez, Virginia, Lacasta, Adelaida, Ruiz-Casado, Ana, Safont, María José, Aparicio, Jorge, Campos, Juan Manuel, Cámara, Juan Carlos, Martín-Richard, Marta, Montagut, Clara, Pericay, Carles, Vieitez, Jose María, Falcó, Esther, Jorge, Mónica, Marín, Miguel, Salgado, Mercedes, Viúdez, Antonio
Publicado 2020

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations

por Brammeld, Jonathan S., Petljak, Mia, Martincorena, Inigo, Williams, Steven P., Alonso, Luz Garcia, Dalmases, Alba, Bellosillo, Beatriz, Robles-Espinoza, Carla Daniela, Price, Stacey, Barthorpe, Syd, Tarpey, Patrick, Alifrangis, Constantine, Bignell, Graham, Vidal, Joana, Young, Jamie, Stebbings, Lucy, Beal, Kathryn, Stratton, Michael R., Saez-Rodriguez, Julio, Garnett, Mathew, Montagut, Clara, Iorio, Francesco, McDermott, Ultan
Publicado 2017

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla(™) KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Hu...

por Solassol, Jérôme, Vendrell, Julie, Märkl, Bruno, Haas, Christian, Bellosillo, Beatriz, Montagut, Clara, Smith, Matthew, O’Sullivan, Brendan, D’Haene, Nicky, Le Mercier, Marie, Grauslund, Morten, Melchior, Linea Cecilie, Burt, Emma, Cotter, Finbarr, Stieber, Daniel, Schmitt, Fernando de Lander, Motta, Valentina, Lauricella, Calogero, Colling, Richard, Soilleux, Elizabeth, Fassan, Matteo, Mescoli, Claudia, Collin, Christine, Pagès, Jean-Christophe, Sillekens, Peter
Publicado 2016

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

por Gonzalez-Cao, Maria, Mayo de las Casas, Clara, Oramas, Juana, Berciano-Guerrero, Miguel A., de la Cruz, Luis, Cerezuela, Pablo, Arance, Ana, Muñoz-Couselo, Eva, Espinosa, Enrique, Puertolas, Teresa, Diaz Beveridge, Roberto, Ochenduszko, Sebastian, Villanueva, Maria-Jose, Basterretxea, Laura, Bellido, Lorena, Rodriguez, Delvys, Campos, Begoña, Montagut, Clara, Drozdowskyj, Ana, Molina, Miguel A., Lopez-Martin, Jose Antonio, Berrocal, Alfonso
Publicado 2021

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

por Bendell, Johanna C., Sauri, Tamara, Gracián, Antonio Cubillo, Alvarez, Rafael, López‐López, Carlos, García‐Alfonso, Pilar, Hussein, Maen, Miron, Maria‐Luisa Limon, Cervantes, Andrés, Montagut, Clara, Vivas, Cristina Santos, Bessudo, Alberto, Plezia, Patricia, Moons, Veerle, Andel, Johannes, Bennouna, Jaafar, van der Westhuizen, Andre, Samuel, Leslie, Rossomanno, Simona, Boetsch, Christophe, Lahr, Angelika, Franjkovic, Izolda, Heil, Florian, Lechner, Katharina, Krieter, Oliver, Hurwitz, Herbert
Publicado 2019

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis

por Solé, Laura, Lobo-Jarne, Teresa, Álvarez-Villanueva, Daniel, Alonso-Marañón, Josune, Guillén, Yolanda, Guix, Marta, Sangrador, Irene, Rozalén, Catalina, Vert, Anna, Barbachano, Antonio, Lop, Joan, Salido, Marta, Bellosillo, Beatriz, García-Romero, Raquel, Garrido, Marta, González, Jessica, Martínez-Iniesta, María, López-Arribillaga, Erika, Salazar, Ramón, Montagut, Clara, Torres, Ferrán, Iglesias, Mar, Celià-Terrassa, Toni, Muñoz, Alberto, Villanueva, Alberto, Bigas, Anna, Espinosa, Lluís
Publicado 2022

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

por Linares, Jenniffer, Sallent-Aragay, Anna, Badia-Ramentol, Jordi, Recort-Bascuas, Alba, Méndez, Ana, Manero-Rupérez, Noemí, Re, Daniele Lo, Rivas, Elisa I., Guiu, Marc, Zwick, Melissa, Iglesias, Mar, Martinez-Ciarpaglini, Carolina, Tarazona, Noelia, Varese, Monica, Hernando-Momblona, Xavier, Cañellas-Socias, Adrià, Orrillo, Mayra, Garrido, Marta, Saoudi, Nadia, Elez, Elena, Navarro, Pilar, Tabernero, Josep, Gomis, Roger R., Batlle, Eduard, Pisonero, Jorge, Cervantes, Andres, Montagut, Clara, Calon, Alexandre
Publicado 2023

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

por Dasari, Arvind, Morris, Van K., Allegra, Carmen J., Atreya, Chloe, Benson, Al B., Boland, Patrick, Chung, Ki, Copur, Mehmet S., Corcoran, Ryan B., Deming, Dustin A., Dwyer, Andrea, Diehn, Maximilian, Eng, Cathy, George, Thomas J., Gollub, Marc J., Goodwin, Rachel A., Hamilton, Stanley R., Hechtman, Jaclyn F., Hochster, Howard, Hong, Theodore S., Innocenti, Federico, Iqbal, Atif, Jacobs, Samuel A., Kennecke, Hagen F., Lee, James J., Lieu, Christopher H., Lenz, Heinz-Josef, Lindwasser, O. Wolf, Montagut, Clara, Odisio, Bruno, Ou, Fang-Shu, Porter, Laura, Raghav, Kanwal, Schrag, Deborah, Scott, Aaron J., Shi, Qian, Strickler, John H., Venook, Alan, Yaeger, Rona, Yothers, Greg, You, Y. Nancy, Zell, Jason A., Kopetz, Scott
Publicado 2020